The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2026 | AI-powered analysis examining mode of presentation and symptoms of colorectal cancer
Guglielmo Vetere, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, outlines findings from an AI-powered analysis examining mode of presentation and symptoms of colorectal cancer. The AI proof-of-concept study extracted clinically meaningful information from unstructured colorectal cancer clinical notes, and high concordance between manual review and AI extraction was achieved. This interview took place at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium in San Francisco, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
